Cautions Concerning Forward-looking Statements
|
|
- Lauren Blankenship
- 5 years ago
- Views:
Transcription
1 1
2 Cautions Concerning Forward-looking Statements These presentations contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position and business strategy. The viewer is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: challenges and uncertainties inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities regarding approval, labeling and other matters that could affect the availability or commercial potential of product candidates; uncertainty of commercial success for new and existing products; the ability of the company to successfully execute strategic plans, including restructuring plans; competition, including technological advances, new products and patents attained by competitors; impact of business combinations and divestitures; challenges to patents; changes to applicable laws and regulations, including global health care reforms; trends toward health care cost containment; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; product efficacy or safety concerns resulting in product recalls or regulatory action; manufacturing difficulties or delays; significant adverse litigation or government action, including related to product liability claims; financial instability of international economies and legal systems; and increased scrutiny of the health care industry by government agencies. A further list and description of these risks, uncertainties and other factors can be found in Johnson & Johnson s Annual Report on Form 10-K for the fiscal year ended January 3, 2016, including in Exhibit 99 thereto, and the company s subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at or on request from Johnson & Johnson. Any forward-looking statement made in these presentations speaks only as of the date of these presentations. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments. 2
3 Notice Regarding Non-GAAP Statements These presentations may refer to certain non-gaap financial measures. These non-gaap financial measures should not be considered replacements for, and should be read together with, the most comparable GAAP financial measures. A reconciliation of certain of these non-gaap financial measures to the most directly comparable GAAP financial measures can be found in the Investor Relations section of the Company s website at Note: Operational sales growth excludes translational currency impact and is a non-gaap financial measure. Notice Regarding Trademarks Third-party trademarks used herein are trademarks of their respective owners. 3
4 Strategic Partnerships, Collaborations and Licensing Arrangements During the course of this morning s presentations, we will discuss a number of products developed in collaboration with strategic partners or licensed from other companies. Following is an acknowledgement of those relationships. Diabetes Care Orthopaedics Surgery Consumer INVOKANA licensed from Mitsubishi Tanabe Pharma Corporation; ANIMAS VIBE in partnership with Dexcom; ONETOUCH VERIO FLEX uses Bluetooth MONOVISC and ORTHOVISC licensed from Anika Therapeutics, Inc.; Kick 2D Surgical Navigation co-developed with Brainlab AG; Various products in connection with the Cooperation Agreement with the AO Foundation; TRUMATCH developed in collaboration with imorphics Ltd and Materialise; CARTO software in partnership with Siemens SURGIFLO research collaboration with Ferrosan Medical Devices A/S ZYRTEC licensed from UCB Inc. and its affiliates; RHINOCORT licensed from AstraZeneca AB 4
5 Art, Science & Ambition Josh Ghaim, Ph.D. Chief Technology Officer, Consumer Alison Lewis Chief Marketing Officer, Consumer 5
6 Transformed Our Brand Building and Innovation Model Power of Art & Science Building Global Brands Differentiated Innovation Pipeline Accelerated Growth Established mega brands and expanded globally Developed a highly differentiated, more valuable innovation pipeline Unlocked accelerated sales and share growth 6
7 All Embedded into a Global Brand Building Framework J&J BRAND SPOTLIGHT Innovation Communication Design Experience BRAND GROWTH PLAN BRAND CREATIVE IDEA CONNECTIONS PLAN EXPERIENCE & CONTENT DEVELOPMENT MEASUREMENT 7
8 That Indexes Above Industry ROI US 1 ROI Indices 2015 EMEA 2 ROI Indices CPG Benchmark Index (Values indexed to Benchmark) TV Digital Print TV Digital Print 1. Based on 2015 mphasize Models, weighted by spend 2. Based on 2015 Neilsen Models in UK, France and Spain, weighted by spend 8
9 Allowing Us to Unlock Brand Value Through Three Growth Pathways Gain global share Grow global consumption Grow global household penetration 9
10 World-class Capabilities Strengthened Our Core Insight-led innovation backed by science R&D capabilities in key Emerging Markets (Brazil, China and India) Global external innovation ecosystem Global quality, regulatory and clinical operations supporting global launches 10
11 Focus on Six Key Consumer Health Growth Categories Beauty OTC Baby Care Oral Health Women s Health Wound Care Aging population Significant unmet need in: Sun Care Anti-aging Aging population Consumer shift to self-care 135 million babies born per year 75% of births in Emerging Markets High incidence of cavities and gum disease Access to care in Emerging Markets Significant unmet need in Emerging Markets Aging population Chronic conditions Consumer shift to self-care Driving Growth through Insight-led Innovation Backed by Scientific Excellence 11
12 Repeatable Insight-led Innovation Model for Growth FOCUS ON FEWER & BIGGER: Differentiated Innovation with Global Scale EXTERNAL FOCUS: Engage World s Best Innovators and Scientists DESIGN THINKING: Consumer and Patient-centric Solutions EXCELLENCE IN SCIENCE: Regulatory and Clinical Excellence Leader in R&D Productivity Partner of Choice Brand Loyalty Professional Endorsement 12
13 Our Innovation Model is Delivering Strong Portfolio Value # of Projects by Launch Year Estimated Portfolio Value by Launch Year -50% 3x vs x vs Data indexed to 2015 number of projects and portfolio value 13
14 Robust Innovation Pipeline in 2016: Launching More Than 100 New Products 14
15 Delivering Transformational Innovation Through Strategic Partnerships External Innovation Over 50 Active Partnerships Globally Emerging Sciences microbiome, biomimicry, 3D printing Strong Innovation Ecosystem academia, entrepreneurs, strategic suppliers collaboration on oral health equity investment in energy based device start-up Health & Technology sensors, personalization, diagnostics Johnson & Johnson Innovation Innovation Centers, JLabs, JJDC and cross-sector collaborations equity investment in new OTC delivery form R&D collaboration leading to an acquisition 1 1. Estimated Q closing 15
16 Design Thinking: Consumer and Patient-centric Solutions insights universal human & health insights to uncover and articulate unmet needs create translate unmet needs into opportunities and create health & well-being solutions Ability to test & learn with speed deliver irresistible product and brand user experiences scale adapt and globally scale solutions with speed 16
17 Excellence in Science and Clinical Efficacy Drives Professional Endorsement Scientific Publications 90% of baby skin publications 48% of skin care publications over 100 oral health publications Regulatory & Clinical Excellence Enterprise capabilities enable us to drive new product innovations classified as medical devices or new drugs by regulatory bodies globally Intellectual Property 1 Strong Professional Endorsement 1 #1 dermatologist recommended Neutrogena patents granted / pending allergist recommended brand Zyrtec hospital recommended Johnson s dentist recommended Listerine 1. US only data 17
18 18
19 Skincare is a Large Category and Caring for the Skin is a Fundamental Need $160 Billion Growing +3% 1 1. Source: Euromonitor, CAGR Skincare is fundamental Skin is the largest organ of the body and its 1 st barrier, providing protection against harsh environmental factors 19
20 Our Ambition is High Today Ranked #2 in US Tomorrow Ranked #1 in US Ranked #4 globally Ranked #2-3 globally Source: Internal estimate 20
21 With Growth Fueled by Four Foundational Areas Power of a Big Idea Globally Scaled Communications Global Market Expansion Re-thinking What s Possible in Innovation 21
22 Neutrogena Elevates the Brand to Unique Space in Beauty At Neutrogena, our job is to allow each woman to put her best face forward. That is why we continue to create, innovate and rethink what is possible in skincare. Health Beauty 22
23 23
24 Neutrogena Poised to Unlock Growth Behind See What s Possible Launched globally in 30 Markets Global PR launch 250MM Reach 2X More than other brands US growth 1 Dermatologist recommended +2 Share points over 2 years 1. US Nielsen 2014 & 2015 Market Share 24
25 Neutrogena Hydro Boost: Best-in-class Skin Hydration Platform Translating insights from Asia into global success Water Gel Matrix with Hyaluronic Acid (absorbs up to 1000x its weight in water) Progressively releases moisture all day long Winning with clinical efficacy, best-in-class product aesthetics and consumer experience 25
26 Neutrogena Sun Care: Powerful Protection + Consumer Preferred Aesthetics Addressing consumer unmet need of performance and aesthetics wet skin technology Powerful protection wet or dry, no dripping, no whitening 26
27 Neutrogena Rapid Wrinkle Repair : Superior Retinol Anti-aging Technology Driving efficacy through formulation and manufacturing know how Before After 50% MORE Retinol Clinically proven to work on even the deepest wrinkles. Results in just 1 week. Building on over 25 years of research on retinol clinical efficacy and safety to drive consumer perceivable results 27
28 Introducing Skin Care for the Digital Generation 28
29 29
30 Introducing Skin Care for the Digital Generation 30
31 31
32 Caring for the World s Babies is Our Calling New moms entering category every day 135 million babies born each year; 75% in emerging markets 73% only use one product during care occasions 32
33 And Re-birthing Our Baby B O R N Build JOHNSON S today! Build Today Own Own New Rituals new rituals Rock Rock Premium premium Nurture Nail Our Future our future 33
34 Grow Baby, Grow! Build Today! Own New Rituals Rock Premium Nurture Our Future New Creative Idea Wipes Innovation Market Expansion Follow Millennial Moms Ages & Stages Innovation Restages Global Activation CAPTURE Diaper Rash Expansion EXPAND New News BabyCenter Owned Asset RETAIN 34
35 Grow Baby, Grow! Build Today! Own New Rituals Rock Premium Nurture Our Future Millennial Relevance / Reach Ages & Stages Innovation CAPTURE EXPAND RETAIN Half Bath Wipe Extra Moisture Head-to-Toe Bedtime Range Emerging Market Pure Protect Shiny Drops 35
36 Grow Baby, Grow! Build Today! Own New Rituals Rock Premium Nurture Our Future Wipes Innovation Diaper Rash Expansion Anchored in Skin Care Benefits Desitin Expansion New Diaper Rash Acquisition 36
37 Grow Baby, Grow! Build Today! Own New Rituals Rock Premium Nurture Our Future Market Expansion German Restage and Market Expansion New News!!!! 37
38 Grow Baby, Grow! Build Today! Own New Rituals Rock Premium Nurture Our Future Digital Acceleration Leveraging Owned Assets Transformational Innovation to Come For JOHNSON S to regain brand relevance, it has to meet changing consumer needs. Innovation is one way. Another way is to identify relevant goals that can be tied to moments that reflect our brand purpose, keeping in mind that JOHNSON S is truly a priceless brand. Powerful Asset 14 markets Covers 73% of JOHNSON S sales 45 million unique visits monthly JOHNSON S: DEFINING THE MASTER BRAND AUGUST 2014?? PAGE 3 38
39 39
40 Listerine Speaks to the Transformative Power of the Brand Spit out impossible and sink your teeth into a life of possible Fully Ready It s Working 40
41 Coupled with the Transformative Power of the Science 5x 2x less plaque less gum disease VS. BRUSHING ALONE Data on file 41
42 Driving More People to Swish Attracting New Users Increasing # of Swishes Million HHS (27% to 53% 1 household penetration) +5 Swishes / Week Twice daily usage $17B MARKET OPPORTUNITY 1. Kantar data, global penetration equal to US penetration 42
43 43
44 And We Are Seeing Bold Results YTD! Market share +1.4 pts to 42.3% Sales +8.0% 1 Live in 80+ Markets simultaneously Digital 1/3 of media mix Professional Recommendations 1. Operational growth, March 2016 YTD excludes Venezuela 44
45 Transformed Our Brand Building and Innovation Model Power of Art & Science Building Global Brands Differentiated Innovation Pipeline Accelerated Growth Established mega brands and expanded globally Developed a highly differentiated, more valuable innovation pipeline Unlocked accelerated sales and share growth 45
46 46
Digital Health Startups A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationSony IR Day Game & Network Services Segment. November 25, Andrew House
Sony IR Day 2014 November 25, 2014 Andrew House President and Group CEO Sony Computer Entertainment Inc. Group Executive in Charge of Network Entertainment Business Sony Corporation Agenda 1. Business
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationLUPIN LIMITED Q3FY17 Investor Presentation February 09, 2017
LUPIN LIMITED Investor Presentation February 09, 2017 Safe Harbor Statement Materials and information provided during this presentation may contain forward-looking statements. These statements are based
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationFeature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
More informationKKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018
KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018 KKR Today Private Markets Public Markets Capital Markets Principal Activities $104bn AUM $91bn AUM Global Franchise $19bn
More informationScienti c Games Debuts First Skill- Based Slot Machine with Classic Arcade Video Game Favorite -- SPACE INVADERS
Scienti c Games Debuts First Skill- Based Slot Machine with Classic Arcade Video Game Favorite -- SPACE INVADERS Innovative new slot integrates authentic alien shooter bonus game, free games, and an option
More informationPareto s Annual Oil & Offshore Conference
Pareto s Annual Oil & Offshore Conference Daniel W. Rabun Chairman, President & CEO 31 August 2011 1 Forward-Looking Statements Statements contained in this presentation that are not historical facts are
More informationGoldman Sachs Medtech Conference, 9 September Dave Illingworth CEO
Goldman Sachs Medtech Conference, 9 September Dave Illingworth CEO 0 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities
More informationHP Delivers World s First Production-Ready 3D Printing System
HP Inc. 1501 Page Mill Road Palo Alto, CA 94304 hp.com News Release HP Delivers World s First Production-Ready 3D Printing System With partners such as Nike and BMW, HP takes major step to reinvent prototyping
More informationTextron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5%
Textron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5% 07/16/2014 PROVIDENCE, R.I.--(BUSINESS WIRE)-- Textron Inc. (NYSE: TXT) today reported
More informationConfirms 2013 Financial Guidance
Confirms 2013 Financial Guidance PROVIDENCE, R.I.--(BUSINESS WIRE)--Jul. 17, 2013-- Textron Inc. (NYSE: TXT) today reported second quarter 2013 income from continuing operations of $0.40 per share, compared
More informationAcquisition of MST Medical Surgery Technologies Ltd:
Acquisition of MST Medical Surgery Technologies Ltd: Meaningfully Bolsters Senhance Platform Innovation to Further Advance Digital Laparoscopy September 24, 2018 2 FORWARD LOOKING STATEMENTS This presentation
More informationDriving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China
Driving profitable growth in Greater China Andy Ho Chief Market Leader Greater China Key takeaways China HealthTech market is the 2 nd largest globally and exhibits continued robust growth with significant
More informationSurgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing
Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Devices), and Sutures (Sutures by Type (Absorbable & Non-Absorbable),
More informationTextron Reports Third Quarter 2014 Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1%
Textron Reports Third Quarter Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1% 10/17/ PROVIDENCE, R.I.--(BUSINESS WIRE)-- Textron Inc. (NYSE: TXT) today reported third
More informationStrategic Alliance Agreement for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd.
Strategic Alliance Agreement for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd. - Aiming to Create New Business Models and Expand Contribution to Patients - March 29, 2018
More informationKey Insight Business Briefing
Promoting physics, supporting physicists Key Insight Business Briefing The role of government in promoting innovation Chairman: Peter Saraga The Institute of Physics 28 April 2008 www.iop.org Promoting
More informationTextron Reports Third Quarter 2018 Results; Narrows Full-Year EPS and Cash Guidance
Corporate Communications Department NEWS Release Textron Reports Third Quarter 2018 Results; Narrows Full-Year EPS and Cash Guidance $468 million returned to shareholders through share repurchases Completed
More informationSafe Harbor Disclosure
Safe Harbor Disclosure Please review our SEC filings on Form 10-K and Form 10-Q The statements contained in this presentation that are not historical facts are forward-looking statements. The company generally
More informationSeptember 12,
September 12, 2013 www.deepwater.com The statements described in this presentation that are not historical facts are forward looking statements within the meaning of Section 27A of the Securities Act of
More informationDealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.
Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:
More informationIn the quarter, Textron returned $344 million to shareholders through share repurchases, compared to $186 million in the first quarter of 2017.
Corporate Communications Department NEWS Release Textron Reports First Quarter 2018 Income from Continuing Operations of $0.72 per Share; Signs Agreement to Sell Tools & Test Business for $810 Million
More informationTextron Reports First Quarter 2016 Income from Continuing Operations of $0.55 per Share, up 19.6%; Reaffirms 2016 Financial Outlook
Textron Reports First Quarter 2016 Income Continuing Operations of $0.55 per Share, up 19.6%; Reaffirms 2016 Financial Outlook April 20, 2016 06:30 AM Eastern Daylight Time PROVIDENCE, R.I.--(BUSINESS
More informationCoatings technology overview
Coatings technology overview Coatings technology and the chemistry of collaboration In a competitive global coatings market, the difference between merely surviving and thriving can often lie in the efficacy
More informationInvestor Presentation October 2013
Investor Presentation October 2013 John Irvin Chief Financial Officer NASDAQ: XONE www.exone.com Safe Harbor Statement These slides and the accompanying oral presentation contains forward-looking statements
More information2 nd Quarter Earnings Conference Call
2 nd Quarter Earnings Conference Call KKR & Co. Inc. Investor Update July 26, 2018 Recent Milestones K-1 $ Converted to a Corporation on July 1, 2018 Investor Day held on July 9, 2018 2 Key Metrics Assets
More informationCredit Suisse Energy Summit Transocean Ltd.
Credit Suisse Energy Summit Transocean Ltd. February 7, 2012 1 Legal Disclaimer The statements described in this presentation that are not historical facts are forward-looking statements within the meaning
More informationCompliance for Eucomed: The Medical Technology Industry s s Perspective
Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big
More informationStarpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationEUROPEAN MANUFACTURING SURVEY EMS
EUROPEAN MANUFACTURING SURVEY EMS RIMPlus Final Workshop Brussels December, 17 th, 2014 Christian Lerch Fraunhofer ISI Content 1 2 3 4 5 EMS A European research network EMS firm-level data of European
More informationJ.P. Morgan Healthcare Conference Summary Transcript
J.P. Morgan Healthcare Conference Summary Transcript Good afternoon, everyone. I'm Shigeo Taniuchi. I'm President and COO of Santen Pharmaceutical. I joined Santen in 1996, and I became the President and
More informationCollegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business
More informationDTI 1998 Competitiveness White Paper: Some background and introduction
DTI 1998 Competitiveness White Paper: Some background and introduction Intellect Knowledge Economy Campaign Knowledge Economy Working Party Meeting Russell Square House 4th November 2003 A personal view
More informationThe partner of choice for self-care products
The partner of choice for self-care products Venture Life Group plc Full Year Results Presentation 2017 22 March 2018 2017 highlights Revenues up 12% to 16.1m (2016: 14.3m) Gross profit increased 18% to
More informationBusiness Models Summary 12/12/2017 1
Business Models Summary 12/12/2017 1 Business Models Summary INDEX 1. Business Models development approach 2. Analysis Framework 3. Analysis of Business Models developed 4. Conclusions 5. Future steps
More informationAnalyst Day Real change starts here. Doug Pferdehirt, Chief Executive Officer
2017 Real change starts here Doug Pferdehirt, Chief Executive Officer Disclaimer Forward-looking statements We would like to caution you with respect to any forward-looking statements made in this commentary
More informationCreating a Premier. Real Life Entertainment Company. July 31, 2017
Creating a Premier Real Life Entertainment Company July 31, 2017 Cautionary Statement Concerning Forward-Looking Projections This presentation contains certain forward-looking statements within the meaning
More informationShell Project Delivery Best Practices Dick L. Wynberg, GM NOV Projects Integrated Gas Shell Global Solutions International B.V
Shell Project Delivery Best Practices Dick L. Wynberg, GM NOV Projects Integrated Gas Shell Global Solutions International B.V SEPTEMBER 26, 2017, ST. PETERSBURG, HOTEL ASTORIA Definitions and cautionary
More informationAnnual General Meeting 2014 Review by the President & CEO. Nina Kopola President & CEO
Annual General Meeting 214 Review by the President & CEO Nina Kopola President & CEO Contents Suominen management Year 213 at a glance Expanding Suominen s business to South America Market review Financial
More informationACCOUNTING TREATMENT OF INTELLECTUAL PROPERTY IN THE PHARMACEUTICAL INDUSTRY
Trakia Journal of Sciences, Vol. 9, No 4, pp 63-68, 2011 Copyright 2011 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7069 (print) ISSN 1313-3551 (online) Original Contribution
More information4 th Quarter Earnings Conference Call
4 th Quarter Earnings Conference Call KKR & Co. Inc. Investor Update February 1, 2019 Key Metrics Assets Under Management Management Fees ($ in billions) ($ in millions) $195 $1,069 $168 $905 $100 $107
More informationNEWS RELEASE. Life sciences companies tout their expertise in India
For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in
More informationAbbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE. January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO
Abbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO FORWARD LOOKING STATEMENT Some statements in this presentation may be forward-looking
More informationFor personal use only
ASX ANNOUNCEMENT AGM PRESENTATION SYDNEY, Monday 21 November 2016: Cellmid Limited (ASX:CDY) provides the following presentation for the Annual General Meeting of the shareholders. End Contact: Maria Halasz,
More informationUNITED INTERNET. Business Applications Strategic Partnership with Warburg Pincus. November 8, Investor Presentation November 8, 2016
UNITED INTERNET Business Applications Strategic Partnership with Warburg Pincus November 8, 2016 1 Investor Presentation November 8, 2016 1&1 INTERNET SE WITHIN UNITED INTERNET GROUP WP XII Venture Holdings
More informationTECHNOLOGY VISION 2017 IN 60 SECONDS
TECHNOLOGY VISION 2017 IN 60 SECONDS GET THE ESSENTIALS THE BIG READ SHORT ON TIME? VIEW HIGHLIGHTS 5 MIN READ VIEW FULL REPORT 45 MIN READ VIEW SHORT REPORT 15 MIN READ OVERVIEW #TECHV1SION2017 2017 TREND
More informationShell s Journey to Mobility
Shell s Journey to Mobility Speakers: Yorinde Knegtering Business Analyst, IT Produce Hydrocarbons Prabhat Mishra Product Owner, PI Center of Excellence Definitions & cautionary note Reserves: Our use
More informationThe Future of Growth and the Energy Industry
The Future of Growth and the Energy Industry July 20, 2017 Grant Thornton LLP. All rights reserved. 1 Our Speakers Steve Toon Editor in Chief Oil and Gas Investor Kevin Schroeder National Managing Partner,
More informationALANCO TECHNOLOGIES INC
SECURITIES & EXCHANGE COMMISSION EDGAR FILING ALANCO TECHNOLOGIES INC Form: 8-K Date Filed: 2016-10-04 Corporate Issuer CIK: 98618 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution
More informationWhy Artificial Intelligence will Revolutionize Healthcare including the Behavioral Health Workforce.
Why Artificial Intelligence will Revolutionize Healthcare including the Behavioral Health Workforce. NDBH Conference New Orleans, LA October 28, 2018 A D I S T I N C T I V E L Y D I V E R S I F I E D E
More informationRoche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.
Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP
More informationIndustry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
More informationInteractive Computing Devices & Applications Based on Intel RealSense Technology
TGM 2014 1 Interactive Computing Devices & Applications Based on Intel RealSense Technology File Download: Go to www.walkermobile.com, Published Material tab, find v1.0 2 Introducing Geoff Walker Senior
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationNetwork-1 Technologies, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationPATENT PROPERTIES ANNOUNCES SECOND QUARTER 2015 RESULTS. Announces Name Change to Walker Innovation Inc.
PATENT PROPERTIES ANNOUNCES SECOND QUARTER 2015 RESULTS Announces Name Change to Walker Innovation Inc. Announces Name Change of its United States Patent Utility Service to Haystack IQ Trial Usage of New
More informationFS INVESTMENTS & KKR FORM STRATEGIC PARTNERSHIP. Combining FSIC & CCT platforms to create stockholder value
FS INVESTMENTS & KKR FORM STRATEGIC PARTNERSHIP Combining FSIC & CCT platforms to create stockholder value FS INVESTMENTS AND KKR TO ESTABLISH INDUSTRY-LEADING PARTNERSHIP FS Investments ( FS ) and KKR
More informationThird Quarter CY 2010 Results. November 04, 2010
Third Quarter CY 2010 Results November 04, 2010 Safe Harbor Disclosure The statements contained in this presentation that are not historical facts are forward-looking statements. The company generally
More informationTHE NEXT WAVE OF COMPUTING. September 2017
THE NEXT WAVE OF COMPUTING September 2017 SAFE HARBOR Forward-Looking Statements Except for the historical information contained herein, certain matters in this presentation including, but not limited
More informationOwens Corning Investor Day. Dave Brown, President and CEO
Owens Corning Investor Day Dave Brown, President and CEO Forward-looking Statement and Non-GAAP Measures This presentation contains forward-looking statements within the meaning of Section 27A of the Securities
More informationpeace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationTHE STARS GROUP 2017 ANNUAL AND SPECIAL MEETING MANAGEMENT PRESENTATION MAY 10, 2018, TORONTO, 11:30 (ET)
Please Note: THE STARS GROUP 2017 ANNUAL AND SPECIAL MEETING MANAGEMENT PRESENTATION MAY 10, 2018, TORONTO, 11:30 (ET) Some of our comments today will contain forward-looking information and statements
More informationTop 50 Emerging Technologies & Growth Opportunities
Top 50 Emerging Technologies & Growth Opportunities Multi-billion Dollar Technologies Ready to Energize Industries and Transform our World THE VALUE PROPOSITION TechVision s annual Top 50 Emerging Technologies
More informationNektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationCommercialization Strategies that Work
Commercialization Strategies that Work Jenny C. Servo, Ph.D. DAWNBREAKER (585)594-0025 DAWNBREAKER Professional Services firm - Rochester, NY Worked with over 1200 SBIR/STTR firms - Department of Energy,
More informationACCELERATING TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017
ACCELERATING TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017 TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017: THROUGH DIGITAL TURBULENCE A powerful combination of market trends, technology developments
More information4 th Quarter Earnings Conference Call
4 th Quarter Earnings Conference Call KKR & Co. L.P. Investor Update February 8, 2018 4Q17 Reflections Fundamentals Are Strong (Dollars in millions, except per unit amounts and unless otherwise stated)
More informationThe Enlightenment of Israeli Innovation-driven Experience to the Economic Development of Suzhou
2018 5th International Conference on Business, Economics and Management (BUSEM 2018) The Enlightenment of Israeli Innovation-driven Experience to the Economic Development of Suzhou Bin Chen Suzhou Vocational
More informationANALYZING START-UP AND INVESTMENT TRENDS IN THE MOBILITY ECOSYSTEM
Matthias Kässer, Thibaut Müller, and Andreas Tschiesner ANALYZING START-UP AND INVESTMENT TRENDS IN THE MOBILITY ECOSYSTEM November 2017 How can companies identify and source the technologies that will
More informationWelcome to the future of energy
Welcome to the future of energy Sustainable Innovation Jobs The Energy Systems Catapult - why now? Our energy system is radically changing. The challenges of decarbonisation, an ageing infrastructure and
More informationGoldman Sachs Global Energy Conference. January 2014
Goldman Sachs Global Energy Conference January 2014 1 Forward-Looking Statements Statements made today that are not historical facts are forward-looking statements within the meaning of Section 27A of
More informationNokia Technologies in 2016 Technology to move us forward.
Business overview Nokia Technologies in 2016 Technology to move us forward. Our advanced technology development and licensing business group, Nokia Technologies, was established with two main objectives:
More informationOperational Intelligence to Deliver Smart Solutions. Copyright 2015 OSIsoft, LLC
Operational Intelligence to Deliver Smart Solutions Presented by John de Koning DEFINITIONS AND CAUTIONARY NOTE Reserves: Our use of the term reserves in this presentation means SEC proved oil and gas
More informationGLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT
GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT CRITICAL THINKING AT THE CRITICAL TIME ABOUT US The Global Risk and Investigations Practice (GRIP) of FTI Consulting is the leading provider of
More informationSPECIAL FEATURE. Supporting Food Demands and Driving Business Growth FUJITSU. Mansour Zadeh, Global CIO, Smithfield Foods, Inc.
FUJITSU SPECIAL FEATURE Supporting Food Demands and Driving Business Growth Mansour Zadeh, Global CIO, Smithfield Foods, Inc. Smithfield Foods, Inc., Supporting Food Demands and Driving Business Growth
More informationApril, 2014 GameAccount Network
April, 2014 Disclaimer Certain statements included in this Presentation contain forward-looking information concerning GameAccount Network's strategy, operations, financial performance or condition, outlook,
More informationPharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationCareer Education Corporation Bear Stearns 2007 SMid-Cap Investor Conference
Career Education Corporation Bear Stearns 2007 SMid-Cap Investor Conference November 13, 2007 Safe Harbor This presentation contains certain forward-looking statements, as defined in Section 21E of the
More informationOperational Intelligence to deliver Smart Solutions
Operational Intelligence to deliver Smart Solutions Presented by John de Koning Shell Global Solutions DEFINITIONS AND CAUTIONARY NOTE Reserves: Our use of the term reserves in this presentation means
More informationGafisa Acquires AlphaVille Urbanismo Conference Call Sao Paulo, October 3 rd, 2006
Gafisa Acquires AlphaVille Urbanismo Conference Call Sao Paulo, October 3 rd, 2006 AlphaVille Developments AlphaVille Graciosa - PR AlphaVille Fortaleza - CE Vila dos Ingleses - MG AlphaVille Campinas
More information$3.5 Billion Acquisition of Nation s No. 2 Company in Growing Moist Snuff Category. Deal at a Glance
Reynolds American Enters Smokeless Tobacco Category Via Acquisition of Conwood $3.5 Billion Acquisition of Nation s No. 2 Company in Growing Moist Snuff Category Deal at a Glance 2005 Financial Summary
More informationChina Ophthalmic Hospital Industry Report, May 2013
China Ophthalmic Hospital Industry Report, 2012-2015 May 2013 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationIntroduction. digitalsupercluster.ca
Introduction digitalsupercluster.ca Government of Canada s Innovation Supercluster Initiative Federal government investing $950MM into superclusters to drive growth, prosperity, jobs and global leadership.
More informationCDP-EIF ITAtech Equity Platform
CDP-EIF ITAtech Equity Platform New financial instruments to support technology transfer in Italy TTO Circle Meeting, Oxford June 22nd 2017 June, 2017 ITAtech: the "agent for change" in TT landscape A
More informationEarly insights of Emerging Sources Citation Index (ESCI): a bibliometrics analysis and overlap mapping method
Early insights of Emerging Sources Citation Index (ESCI): a bibliometrics analysis and overlap mapping method Ying Huang; Beijing Institute of Technology, China Qi Lv; Beijing Institute of Technology,
More informationCanada s Intellectual Property (IP) Strategy submission from Polytechnics Canada
Canada s Intellectual Property (IP) Strategy submission from Polytechnics Canada 170715 Polytechnics Canada is a national association of Canada s leading polytechnics, colleges and institutes of technology,
More informationGuidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation
Guidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation Ministry of Industry and Information Technology National Development and Reform Commission Ministry of Finance
More informationTransforming Surgical Robotics. 34 th Annual J.P. Morgan Healthcare Conference January 14, 2016
1 Transforming Surgical Robotics 34 th Annual J.P. Morgan Healthcare Conference January 14, 2016 Forward Looking Statements 2 This presentation includes statements relating to TransEnterix s current regulatory
More informationNASDAQ: CASI Partnering Presentation
NASDAQ: CASI Partnering Presentation Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to
More informationSanford Bernstein Strategic Decisions Conference. May 2013
Sanford Bernstein Strategic Decisions Conference May 2013 1 Forward-Looking Statements Statements made today that are not historical facts are forward-looking statements within the meaning of Section 27A
More informationSecond Quarter CY 2012 Results. August 2, 2012
Second Quarter CY 2012 Results August 2, 2012 1 Safe Harbor Disclosure Please review our SEC filings on Form 10-K and Form 10-Q The statements contained in this presentation that are not historical facts
More informationWIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants
WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants Topic 12 Managing IP in Public-Private Partnerships, Strategic Alliances,
More informationElectronic Material Systems
Electronic Material Systems Barry Russell Operating Vice President 1 Safe Harbor Statement Today s presentations may contain forward-looking statements within the meaning of the Private Securities Litigation
More informationConnections with Leading Thinkers. Academic Carlos Arruda discusses the problems that must be surmounted to boost innovation in Brazil s economy.
Connections with Leading Thinkers Academic Carlos Arruda discusses the problems that must be surmounted to boost innovation in Brazil s economy. Carlos Arruda is a professor of Innovation and Competitiveness
More informationVenture Capital Search Highlights
Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more
More informationBRAZIL ENERGY AND POWER CONFERENCE. Americo Oliveira McDermott Brazil General Manager September 20, 2015
BRAZIL ENERGY AND POWER CONFERENCE Americo Oliveira McDermott Brazil General Manager September 20, 2015 Forward-Looking Statement In accordance with the Safe Harbor provisions of the Private Securities
More information